Vasodilator-Stimulated Phosphoprotein to Monitor Clopidogrel Posology in a 7-Year-Old Child Stented for a Post-Traumatic Intracranial Internal Carotid Artery Aneurysm

Abstract

Many pediatric medical protocols or drug posology like biantiplatelet therapy are extrapolated from adult care. This association could be indicated in specific pediatric situations such as ischemic stroke, some cardiac conditions, or to control post stent thrombosis/stenosis. If acetylsalicylic acid is commonly used, few data are available about optimal management of clopidogrel in children. We describe the case of a 7-year-old girl admitted to pediatric intensive care unit who undergoes a transitory hemiparesis after a bicycle accident. Brain magnetic resonance imaging reveals a subarachnoid hemorrhage and a wide right Sylvian arachnoid cyst. Hemorrhage predominated at the level of the optochiasmatic cistern, close to the right internal carotid artery. At the same level, angiography revealed a small aneurysm of the internal carotid artery supposed to be a postfalse traumatic aneurysm. The deployment treated this aneurysm of a flow diverter. The treatment was performed under continuous systemic heparin therapy associated with intravenous acetylsalicylic acid, and Clopidogrel was administered immediately after the procedure. An oral bi antiplatelet treatment was initiated the day 2 with acetylsalicylic acid and clopidogrel (1 mg/kg/day). To monitor clopidogrel posology, a vasodilator-stimulated phosphoprotein [VASP]) was performed. The final VASP assay result was 20% for a clopidogrel posology at 0.5 mg/kg/day. Blood pressure and neurological examination were normal during all the hospitalization. VASP assay can be used in children to define the optimal posology of clopidogrel. Further studies are required to determine an optimal initial posology.

Keywords

VASP assay - children - clopidogrel - carotid aneurysm - carotid stent

Publication History

Received: 20 December 2020

Accepted: 09 February 2021

Article published online:
12 April 2021

• References

• 1 El Hassani Y, De Ribaupierre S, Sajadi A, Pereira VM, Rilliet B. [Hemorrhagic strokes in children: etiology and management]. Rev Med Suisse 2010; 6 (237) 401-404 , 406–407
• 2 Sorteberg A, Dahlberg D. Intracranial non-traumatic aneurysms in children and adolescents. Curr Pediatr Rev 2013; 9 (04) 343-352
• 3 Edlow BL, Samuels O. Emergency neurological life support: subarachnoid hemorrhage. Neurocrit Care 2017; 27 (Suppl. 01) 116-123
• 4 Soman T, Rafay MF, Hune S, Allen A, MacGregor D, deVeber G. The risks and safety of clopidogrel in pediatric arterial ischemic stroke. Stroke 2006; 37 (04) 1120-1122
• 5 Finkelstein Y, Nurmohamed L, Avner M, Benson LN, Koren G. Clopidogrel use in children. J Pediatr 2005; 147 (05) 657-661
• 6 Li JS, Yow E, Berezny KY. et al; PICOLO Investigators. Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trial. Circulation 2008; 117 (04) 553-559
• 7 Le Quellec S, Bordet J-C, Negrier C, Dargaud Y. Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literature. Thromb Haemost 2016; 116 (04) 638-650
• 8 Negrotto M, Crosa R, Casagrande W. Assisted coiling using LEO Baby or LVIS Jr stents: report of six cases. Interv Neuroradiol 2015; 21 (05) 566-574
• 9 Fontana P, Bonvini RF, Roffi M. et al. [Evaluating the biological efficacy of clopidogrel: genotype or phenotype?]. Rev Med Suisse 2010; 6 (235) 302-305
• 10 Trivelato FP, Rezende MTS, Fonseca LV, Bonadio LE, Ulhôa AC, Abud DG. Pipeline embolization device for the treatment of a traumatic intracranial aneurysm in a child. Childs Nerv Syst 2017; 33 (05) 869-872
• 11 Kuliczkowski W, Rychlik B, Chiżyński K, Watała C, Golański J. Comparison of the VASP assay and platelet aggregometry in the evaluation of platelet P2Y12 receptor blockade. Pol Arch Med Wewn 2011; 121 (04) 115-121
• 12 Cuisset T, Grosdidier C, Loundou AD. et al. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs). JACC Cardiovasc Interv 2013; 6 (08) 854-863
• 13 Wang T, Zhang CW, Richard SA, Chaohua W, Xie XD. Reactive in-stent stenosis of a pipeline embolization device in a child: a case report. Medicine (Baltimore) 2019; 98 (47) e18092
• 14 Wang Z, Xie Q, Xiang Q, Gong Y, Jiang J, Cui Y. Predictive value of methods measuring platelet activation for ischemic events in patients receiving clopidogrel: a systematic review and meta-analysis. Curr Pharm Des 2018; 24 (44) 5313-5333